For the Inventor, By the Inventor

Enter inventor name

Amesbury, MA, United States of America

Keith A Moulton

This inventor holds 24 USPTO granted patents and 4 published patent applications and 1 EPO patent, primarily in Quantitative Imaging. Top assignees: Elucid Bioimaging Inc., Thrive Bioscience, Inc., Elucid Bioiwaging Inc.. Active years: 2019-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Keith A Moulton. Retrieved from https://idiyas.com/inventor/keith-a-moulton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 24 (Patent Applications = 4)

% Patents Active = 100.0

EPO Patents = 1

Average Co-Inventor Count = 5.1

ph-index = 14

Forward Citations = 734(Granted Patents)

Company Filing History:

Elucid Bioimaging Inc.

Thrive Bioscience, Inc.

Elucid Bioiwaging Inc.

Years Active: 2019-2025

Loading Chart...

Loading Chart...

Areas of Expertise:

Quantitative Imaging

Cardiovascular Disease

Atherosclerotic Plaque

Non-Invasive Imaging

Patient Care

CT Angiography

Risk Stratification

Biomarkers

Myocardial Ischemia

Phenotyping

Molecular Profiles

Stenosis

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12236595 - Characterizing permeability, neovascularization, necrosis, collagen breakdown, or inflammation (2025-02-25),

2. 12229957 - Systems and methods for diagnostics for management of cardiovascular disease patients (2025-02-18),

3. 12159406 - Determining biological properties of atherosclerotic plaque, coronary artery disease, or vasculopathy (2024-12-03),

4. 12141975 - Myocardial ischemia prediction (2024-11-12),

5. 12136214 - Non-invasive imaging to inform patient care (2024-11-05),

6. 12131472 - Non-invasive imaging to determine health and disease (2024-10-29),

7. 12131471 - Longitudinal change measures for optimizing patient care (2024-10-29),

8. 12106477 - Segmenting permeability, neovascularization, necrosis, collagen breakdown, or inflammation to characterize atherosclerotic plaque, coronary artery disease, or vasculopathy (2024-10-01),

9. 12073561 - Multiscale modeling to determine molecular profiles from radiology (2024-08-27),

10. 12045983 - Functional measures of stenosis significance (2024-07-23),

11. 12039765 - Systems and methods for optimizing analysis of CT angiography (2024-07-16),

12. 11884913 - Instrument resource scheduling (2024-01-30),

13. 11676359 - Non-invasive quantitative imaging biomarkers of atherosclerotic plaque biology (2023-06-13),

14. 11607179 - Non-invasive risk stratification for atherosclerosis (2023-03-21),

15. 11120312 - Quantitative imaging for cancer subtype (2021-09-14),

Title: Inventor Keith A Moulton

Introduction: Keith A Moulton is a renowned inventor based in Amesbury, MA (US) known for his innovative contributions in various fields.

Latest Patents: Keith A Moulton holds several patents in the areas of technology and engineering, with his most recent patent focusing on sustainable energy solutions.

Career Highlights: Throughout his career, Keith A Moulton has been recognized for his groundbreaking inventions that have significantly impacted industries such as renewable energy, transportation, and healthcare.

Collaborations: Keith A Moulton has collaborated with leading research institutions, universities, and companies to further develop and implement his inventions on a global scale.

Conclusion: Keith A Moulton's dedication to innovation and his passion for creating solutions to complex challenges have solidified his reputation as a pioneering inventor in Amesbury, MA (US).

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…